Thermo Fisher pledges to reach carbon neutrality by 2050
Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change
Thermo Fisher Scientific has announced its commitment to achieve net-zero carbon emissions by 2050, a decision that advances the company's current strategy to mitigate its impact on the environment.
Back in 2019, the company set targets to reduce greenhouse gas (GHG) emissions across its operations (Scopes 1 and 2) by 2030. These goals are aligned with the criteria of the Science Based Targets initiative (SBTi).
Thermo Fisher's new pledge to reach carbon neutrality by 2050 incorporates additional targets to reduce its value chain emissions (Scope 3), including a commitment to SBTi's most ambitious guidelines. It also supports the global goals of the Paris Climate Agreement and the United Nations' Race To Zero campaign.
The company has already made strides towards achieving its net zero commitment by making its facilities more energy efficient, increasing the use of renewable energy and reducing waste in its operations.
Thermo Fisher said it also plays a role in advancing climate science — its analytical instruments spur the creation of green technologies and allow researchers to further investigate global warming, all of which help enable customers and partners to achieve their climate goals.
Marc N. Casper, chairman, president and chief executive officer, Thermo Fisher Scientific, said the endeavour to reach the 2050 target will engage each member of the company's 80,000 strong workforce to address climate change.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance